Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 44

1.

Complete Genome Sequence of Mycoplasma bovis Strain KG4397, Isolated from Cattle in Japan.

Morimoto M, Kenri T, Ohmori T, Teshima K, Shibuya K, Sasakawa C, Suzuki M.

Microbiol Resour Announc. 2019 Oct 3;8(40). pii: e00838-19. doi: 10.1128/MRA.00838-19.

2.

Genetic characterization of Mycoplasma pneumoniae isolated in Osaka between 2011 and 2017: Decreased detection rate of macrolide-resistance and increase of p1 gene type 2 lineage strains.

Katsukawa C, Kenri T, Shibayama K, Takahashi K.

PLoS One. 2019 Jan 25;14(1):e0209938. doi: 10.1371/journal.pone.0209938. eCollection 2019.

3.

Production and characterization of recombinant P1 adhesin essential for adhesion, gliding, and antigenic variation in the human pathogenic bacterium, Mycoplasma pneumoniae.

Kenri T, Kawakita Y, Kudo H, Matsumoto U, Mori S, Furukawa Y, Tahara YO, Shibayama K, Hayashi Y, Arai M, Miyata M.

Biochem Biophys Res Commun. 2019 Jan 22;508(4):1050-1055. doi: 10.1016/j.bbrc.2018.11.132. Epub 2018 Dec 11.

4.

Complete Genome Sequences of the p1 Gene Type 2b and 2c Strains Mycoplasma pneumoniae KCH-402 and KCH-405.

Kenri T, Suzuki M, Horino A, Sekizuka T, Kuroda M, Fujii H, Hashimoto T, Nakajima H, Ohya H, Shibayama K.

Genome Announc. 2017 Jun 15;5(24). pii: e00513-17. doi: 10.1128/genomeA.00513-17.

5.

Pelvic abscess due to Mycoplasma hominis following caesarean section.

Mori N, Takigawa A, Kagawa N, Kenri T, Yoshida S, Shibayama K, Aoki Y.

JMM Case Rep. 2016 Aug 30;3(4):e005059. doi: 10.1099/jmmcr.0.005059. eCollection 2016 Aug.

6.

Therapeutic efficacy of azithromycin, clarithromycin, minocycline and tosufloxacin against macrolide-resistant and macrolide-sensitive Mycoplasma pneumoniae pneumonia in pediatric patients.

Ishiguro N, Koseki N, Kaiho M, Ariga T, Kikuta H, Togashi T, Oba K, Morita K, Nagano N, Nakanishi M, Hara K, Hazama K, Watanabe T, Yamanaka T, Sasaki S, Furuyama H, Shibata M, Shida S, Ishizaka A, Tabata Y, Aoyagi H, Naito H, Yoshioka M, Horino A, Kenri T; Hokkaido Pediatric Respiratory Infection Study Group.

PLoS One. 2017 Mar 13;12(3):e0173635. doi: 10.1371/journal.pone.0173635. eCollection 2017.

7.

Inter- and intra-strain variability of tandem repeats in Mycoplasma pneumoniae based on next-generation sequencing data.

Zhang J, Song X, Ma MJ, Xiao L, Kenri T, Sun H, Ptacek T, Li S, Waites KB, Atkinson TP, Shibayama K, Dybvig K, Feng Y.

Future Microbiol. 2017 Feb;12:119-129. doi: 10.2217/fmb-2016-0111. Epub 2016 Oct 12.

8.

Epidemiology of Mycoplasma pneumoniae Infections in Japan and Therapeutic Strategies for Macrolide-Resistant M. pneumoniae.

Yamazaki T, Kenri T.

Front Microbiol. 2016 May 23;7:693. doi: 10.3389/fmicb.2016.00693. eCollection 2016. Review.

9.

Systematic Structural Analyses of Attachment Organelle in Mycoplasma pneumoniae.

Nakane D, Kenri T, Matsuo L, Miyata M.

PLoS Pathog. 2015 Dec 3;11(12):e1005299. doi: 10.1371/journal.ppat.1005299. eCollection 2015 Dec.

10.

[A Study on the Clinical Course and Antimicrobial Susceptibility of Mycoplasma pneumoniae in a Community Hospital].

Sakai T, Ishida T, Arita M, Tachibana H, Yoshioka H, Noyama M, Tokioka F, Ito A, Furuta K, Nishiyama A, Hashimoto T, Fujii H, Nakajima H, Kenri T, Shibayama K.

Kansenshogaku Zasshi. 2015 Jul;89(4):458-64. Japanese.

PMID:
26554221
11.

Regional Differences in Prevalence of Macrolide Resistance among Pediatric Mycoplasma pneumoniae Infections in Hokkaido, Japan.

Ishiguro N, Koseki N, Kaiho M, Kikuta H, Togashi T, Oba K, Morita K, Nagano N, Nakanishi M, Hazama K, Watanabe T, Sasaki S, Horino A, Kenri T, Ariga T; Hokkaido Pediatric Respiratory Infection Study Group.

Jpn J Infect Dis. 2016 May 20;69(3):186-90. doi: 10.7883/yoken.JJID.2015.054. Epub 2015 Jul 10.

12.

Genetic characterization and comparison of Clostridium botulinum isolates from botulism cases in Japan between 2006 and 2011.

Kenri T, Sekizuka T, Yamamoto A, Iwaki M, Komiya T, Hatakeyama T, Nakajima H, Takahashi M, Kuroda M, Shibayama K.

Appl Environ Microbiol. 2014 Nov;80(22):6954-64. doi: 10.1128/AEM.02134-14. Epub 2014 Sep 5.

13.

Identification of Mycoplasma pneumoniae type 2b variant strains in Japan.

Kenri T, Ohya H, Horino A, Shibayama K.

J Med Microbiol. 2012 Nov;61(Pt 11):1633-5. doi: 10.1099/jmm.0.046441-0. Epub 2012 Aug 16. No abstract available.

PMID:
22899779
14.

Corynebacterium ulcerans 0102 carries the gene encoding diphtheria toxin on a prophage different from the C. diphtheriae NCTC 13129 prophage.

Sekizuka T, Yamamoto A, Komiya T, Kenri T, Takeuchi F, Shibayama K, Takahashi M, Kuroda M, Iwaki M.

BMC Microbiol. 2012 May 14;12:72. doi: 10.1186/1471-2180-12-72.

15.

Complete genome sequence of Mycoplasma pneumoniae type 2a strain 309, isolated in Japan.

Kenri T, Horino A, Matsui M, Sasaki Y, Suzuki S, Narita M, Ohya H, Okazaki N, Shibayama K.

J Bacteriol. 2012 Mar;194(5):1253-4. doi: 10.1128/JB.06553-11.

16.

Disinfection methods for spores of Bacillus atrophaeus, B. anthracis, Clostridium tetani, C. botulinum and C. difficile.

Oie S, Obayashi A, Yamasaki H, Furukawa H, Kenri T, Takahashi M, Kawamoto K, Makino S.

Biol Pharm Bull. 2011;34(8):1325-9.

17.

Isolation and characterization of P1 adhesin, a leg protein of the gliding bacterium Mycoplasma pneumoniae.

Nakane D, Adan-Kubo J, Kenri T, Miyata M.

J Bacteriol. 2011 Feb;193(3):715-22. doi: 10.1128/JB.00796-10. Epub 2010 Nov 19.

18.

Identification of a site-specific tyrosine recombinase that mediates promoter inversions of phase-variable mpl lipoprotein genes in Mycoplasma penetrans.

Horino A, Kenri T, Sasaki Y, Okamura N, Sasaki T.

Microbiology. 2009 Apr;155(Pt 4):1241-9. doi: 10.1099/mic.0.025437-0.

PMID:
19332825
19.

Mycoplasma hominis meningitis in a neonate: case report and review.

Hata A, Honda Y, Asada K, Sasaki Y, Kenri T, Hata D.

J Infect. 2008 Oct;57(4):338-43. doi: 10.1016/j.jinf.2008.08.002. Epub 2008 Sep 14. Review.

PMID:
18790539
20.

Genotyping analysis of Mycoplasma pneumoniae clinical strains in Japan between 1995 and 2005: type shift phenomenon of M. pneumoniae clinical strains.

Kenri T, Okazaki N, Yamazaki T, Narita M, Izumikawa K, Matsuoka M, Suzuki S, Horino A, Sasaki T.

J Med Microbiol. 2008 Apr;57(Pt 4):469-75. doi: 10.1099/jmm.0.47634-0.

PMID:
18349367
21.

Enhancement of cytotoxicity against Vero E6 cells persistently infected with SARS-CoV by Mycoplasma fermentans.

Mizutani T, Fukushi S, Kenri T, Sasaki Y, Ishii K, Endoh D, Zamoto A, Saijo M, Kurane I, Morikawa S.

Arch Virol. 2007;152(5):1019-25. Epub 2007 Feb 7.

PMID:
17277901
22.

Mechanisms of establishment of persistent SARS-CoV-infected cells.

Mizutani T, Fukushi S, Ishii K, Sasaki Y, Kenri T, Saijo M, Kanaji Y, Shirota K, Kurane I, Morikawa S.

Biochem Biophys Res Commun. 2006 Aug 18;347(1):261-5. Epub 2006 Jun 22.

PMID:
16808902
23.

Comparison of PCR for sputum samples obtained by induced cough and serological tests for diagnosis of Mycoplasma pneumoniae infection in children.

Yamazaki T, Narita M, Sasaki N, Kenri T, Arakawa Y, Sasaki T.

Clin Vaccine Immunol. 2006 Jun;13(6):708-10.

24.

Clinical evaluation of macrolide-resistant Mycoplasma pneumoniae.

Suzuki S, Yamazaki T, Narita M, Okazaki N, Suzuki I, Andoh T, Matsuoka M, Kenri T, Arakawa Y, Sasaki T.

Antimicrob Agents Chemother. 2006 Feb;50(2):709-12.

26.

Characterization and molecular analysis of macrolide-resistant Mycoplasma pneumoniae clinical isolates obtained in Japan.

Matsuoka M, Narita M, Okazaki N, Ohya H, Yamazaki T, Ouchi K, Suzuki I, Andoh T, Kenri T, Sasaki Y, Horino A, Shintani M, Arakawa Y, Sasaki T.

Antimicrob Agents Chemother. 2004 Dec;48(12):4624-30.

27.
28.

[The genetic view of Mycoplasma infections].

Kenri T.

Nihon Rinsho. 2003 Mar;61 Suppl 3:772-8. Review. Japanese. No abstract available.

PMID:
12718063
29.

Multiple promoter inversions generate surface antigenic variation in Mycoplasma penetrans.

Horino A, Sasaki Y, Sasaki T, Kenri T.

J Bacteriol. 2003 Jan;185(1):231-42.

30.

The complete genomic sequence of Mycoplasma penetrans, an intracellular bacterial pathogen in humans.

Sasaki Y, Ishikawa J, Yamashita A, Oshima K, Kenri T, Furuya K, Yoshino C, Horino A, Shiba T, Sasaki T, Hattori M.

Nucleic Acids Res. 2002 Dec 1;30(23):5293-300.

31.

Characteristics of macrolide-resistant Mycoplasma pneumoniae strains isolated from patients and induced with erythromycin in vitro.

Okazaki N, Narita M, Yamada S, Izumikawa K, Umetsu M, Kenri T, Sasaki Y, Arakawa Y, Sasaki T.

Microbiol Immunol. 2001;45(8):617-20.

32.
33.

[Clinicobacteriological studies on the nine cases with upper genital tract Mycoplasma hominis infection].

Shimada M, Kotani T, Ohtaki S, Sameshima H, Ikenoue T, Sasaki T, Kenri T.

Kansenshogaku Zasshi. 1999 Jul;73(7):646-51. Japanese.

PMID:
10481399
34.
35.

Two patients with premature labour associated with Mycoplasma hominis infection.

Shimada M, Kotani T, Sameshima H, Nagamine Y, Kodama Y, Ikenoue T, Kenri T, Sasaki T, Ohtaki S.

J Med Microbiol. 1998 Feb;47(2):179-82.

PMID:
9879962
36.

Direct evidence of autosomal recessive inheritance of Arg24 to termination codon in purine nucleoside phosphorylase gene in a family with a severe combined immunodeficiency patient.

Sasaki Y, Iseki M, Yamaguchi S, Kurosawa Y, Yamamoto T, Moriwaki Y, Kenri T, Sasaki T, Yamashita R.

Hum Genet. 1998 Jul;103(1):81-5.

PMID:
9737781
37.

Identification and characterization of HU protein from Mycoplasma gallisepticum.

Kenri T, Sasaki T, Kano Y.

Biochem Biophys Res Commun. 1998 Aug 10;249(1):48-52.

PMID:
9705829
38.

Evaluation of a new method for identification of bacteria based on sequence homology of 16S rRNA gene.

Sasaki T, Nishiyama T, Shintani M, Kenri T.

PDA J Pharm Sci Technol. 1997 Nov-Dec;51(6):242-7.

PMID:
9448434
39.

Application of PCR for detection of mycoplasma DNA and pestivirus RNA in human live viral vaccines.

Sasaki T, Harasawa R, Shintani M, Fujiwara H, Sasaki Y, Horino A, Kenri T, Asada K, Kato I, Chino F.

Biologicals. 1996 Dec;24(4):371-5.

PMID:
9088554
40.

Evaluation of current sterility tests for human live viral vaccines.

Sasaki T, Harasawa R, Shintani M, Fujiwara H, Sasaki Y, Horino A, Kenri T, Ishii K, Chino F.

Biologicals. 1996 Mar;24(1):51-5.

PMID:
8733601
41.

Epidemiological study of Mycoplasma pneumoniae infections in japan based on PCR-restriction fragment length polymorphism of the P1 cytadhesin gene.

Sasaki T, Kenri T, Okazaki N, Iseki M, Yamashita R, Shintani M, Sasaki Y, Yayoshi M.

J Clin Microbiol. 1996 Feb;34(2):447-9.

42.
44.

Construction and characterization of an Escherichia coli mutant with a deletion of the metZ gene encoding tRNA (f1Met).

Kenri T, Kohno K, Goshima N, Imamoto F, Kano Y.

Gene. 1991 Jul 15;103(1):31-6.

PMID:
1715303

Supplemental Content

Support Center